These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6294519)

  • 1. Treatment of multiple sclerosis.
    McFarlin DE
    N Engl J Med; 1983 Jan; 308(4):215-7. PubMed ID: 6294519
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
    Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Propper RD; Mills JA; Weiner HL
    N Engl J Med; 1983 Jan; 308(4):173-80. PubMed ID: 6294517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1989; 23(3):188-92. PubMed ID: 2561379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1988; 22(5):399-403. PubMed ID: 2854886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis and treatment of multiple sclerosis. Review and personal results].
    Gérard JM; Hildebrand J; Mavroudakis N; Monseu G; Przedborski S; Seeldrayers P; Wautier J; Zegers de Beyl D
    Rev Med Brux; 1988 Sep; 9(6):334-9. PubMed ID: 2845554
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC
    NITA; 1985; 8(6):503-5. PubMed ID: 2999647
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S; Hohlfeld R
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperbaric oxygen treatment in multiple sclerosis.
    Wilkinson R; Johnson R
    N Z Med J; 1987 Jan; 100(816):8-9. PubMed ID: 3543761
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of multiple sclerosis with hyperbaric oxygen].
    van Crevel H; Bakker DJ; Zegerius L
    Ned Tijdschr Geneeskd; 1985 May; 129(20):936-7. PubMed ID: 3894995
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperbaric oxygen therapy in multiple sclerosis.
    Bates D
    Br J Hosp Med; 1986 Jun; 35(6):365. PubMed ID: 3521780
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
    Dawson DM; Carter JL; Hafler DA; Weiner HL
    Riv Neurol; 1987; 57(2):88-91. PubMed ID: 3039645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current methods of therapy in multiple sclerosis.
    Sibley WA
    Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperbaric oxygen treatment for multiple sclerosis.
    Adamson L
    Nurs Times; 1985 Nov 20-26; 81(47):47-8. PubMed ID: 3906577
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperbaric oxygen treatment for multiple sclerosis.
    Davidson DL
    Practitioner; 1984 Oct; 228(1396):903-5. PubMed ID: 6384987
    [No Abstract]   [Full Text] [Related]  

  • 16. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
    Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
    Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of hyperbaric oxygen therapy on the visual evoked potentials of patients with multiple sclerosis].
    Maillard P; Clanet M; Bourdiol AM; Arne JL
    Bull Soc Ophtalmol Fr; 1987 Jan; 87(1):43-5. PubMed ID: 3301038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J
    Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
    Carter JL; Hafler DA; Dawson DM; Orav J; Weiner HL
    Neurology; 1988 Jul; 38(7 Suppl 2):9-14. PubMed ID: 2838768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with cyclophosphamide in multiple sclerosis: the cons.
    Likosky WH
    Neurology; 1988 Jul; 38(7 Suppl 2):14-8. PubMed ID: 3290708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.